Results of Helicobacter pylori screening and eradication in a multi-ethnic community in central England

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 11, 1998, Pages 957-962

  Stone, Margaret A ^a,b   Patel, Hemlata ^a   Panja, Kishan K ^a   Barnett, David B ^a   Mayberry, John F ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

Clarithromycin; Eradication; Ethnic groups; Helicobacter pylori; Prevalence; Ranitidine bismuth citrate

Indexed keywords

CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; MACROLIDE; RANITIDINE BISMUTH CITRATE; UREA;

ADULT; ARTICLE; ASIAN; BREATH ANALYSIS; CITY; ETHNIC GROUP; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCREENING; UNITED KINGDOM; URBAN POPULATION;

EID: 0031742309     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199811000-00010     Document Type: Article

References (31)

1. National Institutes of Health Consensus Conference on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272:65-69.
2. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341:1359-1362.
3. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71:437-439.
4. Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, Filipe MI, et al. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori. Gut 1988; 29:1386-1391.
5. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative results from a large, prospective study. BMJ 1997; 315:1199-1201.
6. Talley NJ. Helicobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol 1996; 31(suppl 220):19-22.
7. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996; 348:150-154.
8. Moayyedi P, Axon ATR. Is there a rationale for eradication of Helicobacter pylori? Cost benefit: the case for. Br Med Bull 1998; 54:243-250.
9. Patchett SE. Helicobacter pylori eradication. Cost benefit: the case against. Br Med Bull 1998; 54:251-257.
10. Stone MA, Patel H, Panja KK, Barnett DB, Mayberry JF. Reasons for non-compliance with screening for infection with Helicobacter pylori, in a multiethnic community in Leicester, UK. Public Health 1998; 112:153-156.
11. Stone MA, Barnett DB, Mayberry JF. Lack of correlation between self-reported symptoms of dyspepsia and infection with Helicobacter pylori, in a general population sample. Eur J Gastroenterol Hepatol 1998: 10:301-304.
12. Stone MA, Barnett DB, Mayberry JF. General population screening for infection with Helicobacter pylori: a realistic option? J Med Screen 1998; 5:162-166.
13. 13C-urea breath test [abstract]. Gut 1996; 39(suppl 2):A122.
14. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race and socioeconomic status. Gastroenterology 1991; 100:1495-1501.
15. Perez-Perez GI, Witkin SS, Decker MD, Blaser MJ. Seroprevalence of Helicobacter pylori infection in couples. J Clin Microbiol 1991; 29:642-644.
16. Lin SK, Lambert JR, Chow T, Schembri M, Nicholson L, Wahlqvist M, et al. Comparison of H. pylori in three ethnic groups - evidence of oral-oral transmission [abstract]. Gastroenterology 1991; 100:A111.
17. Seery JP, Henshaw DJ, Sandhu PJ, Mather HM, Ahmed F, McNeil I, et al. Helicobacter pylori infection and upper gastrointestinal pathology in a British immigrant Indian community. Eur J Gastroenterol Hepatol 1997; 9:191-194.
18. Harvey JM, Battcock TM, Wicks ACB. Asian endoscopies: is there a difference? Postgrad Med J 1991; 67:897-899.
19. Stone MA, Mayberry JF, Wicks ACB, Livsey SA, Stevens M, Swann RA, et al. Near patient testing for Helicobacter pylori: a detailed evaluation of the Cortecs Helisal Rapid Blood Test. Eur J Gastroenterol Hepatol 1997; 9:257-260.
20. Webb PM, Knight T, Greaves S, Wilson A, Newell DG, Elder J, et al. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ 1994; 308:750-753.
21. Ashorn M, Maki M, Hallstrom M, Uhari M, Akerblom HK, Viikari J, et al. Helicobacter pylori infection in Finnish children and adolescents. A serologic cross-sectional and follow-up study. Scand J Gastroenterol 1995; 30:876-879.
22. Graham DY, Adam E, Reddy GT, Agarwal JP, Agarwal R, Evans DJ, et al. Seroepidemiology of Helicobacter pylori infection in India. Dig Dis Sci 1991; 36:1084-1088.
23. Katelaris PH, Tippett GHK, Norbu P, Lowe DG, Brennan R, Farthing MJG. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut 1992; 33:1462-1466.
24. Coelho LG, Passos MC, Chausson Y, Cost EL, Maia AF, Brandao MJ, et al. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18 month follow-up study. Scand J Gastroenterol 1992; 27:362-366.
25. Gill HH, Majmudar P, Shankaran K, Desai HG. Age-related prevalence of Helicobacter pylori antibodies in Indian subjects. Indian J Gastroenterol 1994; 13:92-94.
26. Tovey FI. Helicobacter pylori infection and upper gastrointestinal pathology in a British immigrant Indian community [letter]. Eur J Gastroenterol Hepatol 1997; 9:647-648.
27. Banatvala N, Davies GR, Abdi Y, Clements L, Rampton DS, Hardie JM, et al. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidizole exposure and gastroduodenal disease. Gut 1994; 35:1562-1566.
28. Paré P, Romaozinho J, Bardhan KD, French PC, Roberts PM. Ranitidine bismuth citrate (RBC) is more effective than omeprazole in the eradication of H. pylori when co-prescribed with clarithromycin [abstract]. Gastroenterology 1997; 112:A251.
29. British Medical Association and Royal Pharmaceutical Association. British National Formulary, Number 34. London: The Pharmaceutical Press; 1997.
30. The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41:8-13.
31. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1 -week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7:835-840.